BioHealth News Archive
Altimmune Raises $17 Million through Underwritten Public & Registered Direct Offerings Last Week
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced the pricing of an underwritten public offering of common units and pre-funded units for…
Read More
Maryland Tech Council’s Venture Mentoring Program Expands to Serve Entrepreneurs Across Maryland
Maryland Tech Council (MTC) announced today that, with the support of the Maryland Department of Commerce, the Maryland Tech Council Venture Mentoring Services (MTC…
Read More
Aldrich Capital Partners raises new fund – Washington Business Journal
The fund aims to invest in larger, more mature companies primed for growth. {iframe}https://www.bizjournals.com/washington/news/2018/10/03/vienna-venture-firm-closes-new-outside-fund-thats.html?ana=e_mc_prem&s=newsletter&ed=2018-10-03&u=bMjmanq9kRPlhJk8oGksWA0bfd6cfb&t=1538569136&j=84174741{/iframe}
Read More
The right way for health systems to embrace startup innovation
Many health systems acknowledge that partnering with digital healthcare startups is a necessary step toward innovation, but if providers do not tend these partnerships…
Read More
CASI Pharmaceuticals Announces Appointment Of President To Its China Operations To Lead Commercialization
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to…
Read More
Innovations in Viral Clearance – GEN
Viral clearance is not a new challenge for the biopharmaceutical industry. However, regulatory demand for better data combined with the growing recognition of the shortcomings of…
Read More
Save the Dates: Montgomery Innovation Academy
BHI and Launch Workplaces are co-hosting a series informational programs on topics of interest to early stage companies in Montgomery County’s innovation network. Geared…
Read More
Rockville Innovation Center tenant, Children’s Hospital spinout ReveraGen Announces First Patient Enrollment in International Pivotal Trial of Vamorolone in Duchenne Muscular Dystrophy
ReveraGen BioPharma, Inc. today announced the initiation and first patient enrollment in a double-blind, placebo- and prednisone-controlled clinical trial (VBP15-004) of vamorolone, a first-in-class…
Read More
New Division at NIH Seeking Director
The National Institutes of Health (NIH) Office of Extramural Research (OER) provides the corporate framework for NIH research administration, ensuring scientific integrity, public accountability,…
Read More
2018 Nobel Prize in Medicine Awarded to 2 Cancer Immunotherapy Researchers – The New York Times
The 2018 Nobel Prize in Physiology or Medicine was awarded on Monday to James P. Allison of the United States and Tasuku Honjo of…
Read More
Roche to acquire immuno-oncology company Tusk Therapeutics – PharmaLive
Swiss-based Roche announced it is buying UK-based Tusk Therapeutics in a deal that could hit $758 million (U.S.). Under the terms of the acquisition, Roche…
Read More
FDA Approves Expanded Use of Qiagen EGFR CDx in Lung Cancer | GenomeWeb
Qiagen announced today that the US Food and Drug Administration has approved the expanded use of the company's Therascreen EGFR RGQ PCR Kit to…
Read More
NIH awards $5.1M to Hopkins team developing fast diagnostic tool for sexually transmitted diseases | Hub
New cases of sexually transmitted diseases are on the rise worldwide, and some strains have become resistant to the antibiotics commonly used to treat…
Read More
New report for medtech industry has stark message: Tech coming for you – MedCity News
A report released this week at the annual conference of the trade association for medical device and diagnostics companies had a stark message to…
Read More
VC funding is on a roll in Maryland | Maryland Business News
Summer 2018 may have brought more rain than sun, but when it comes to funding at Maryland startups, things have been hot, hot, hot.…
Read More